Wall Street Numbers logo
Wall Street Numbers logo
Wall Street Numbers
Teva Pharmaceutical Industries Limited company logo
Teva Pharmaceutical Industries Limited logo

Teva Pharmaceutical Industries Limited (TEVA)

Profile

Company profile for Teva Pharmaceutical Industries Limited (TEVA)
MetricValue
Full NameTeva Pharmaceutical Industries Limited
TickerNYSE: TEVA
ExchangeNYSE
SectorHealthcare
IndustrySpecialty & Generic Drug Manufacturers
CountryIsrael
IPO
IndexesNot included
Websitetevapharm.com
Employees37,000

Key Metrics

Teva Pharmaceutical Industries Limited Key Details
MetricDateValue
Price$32.11
Price, 1D Change+3.58%
Market Cap$37B
TTM Dividend Yield-
PE Ratio52.36
Beta0.95
Revenue$17B
Revenue, 1Y Change+4.67%
EPS-$1.46
EPS, 1Y Change-191.49%

Chart

Add series to chart(max: 6)
Series
SUGGESTED SERIES
Teva Pharmaceutical Industries Limited chart

Events

Teva Pharmaceutical Industries Limited Events
MetricDateValue
Next Earnings
Last Qtr. Earnings
Last Ann. Earnings
Last Ex-Dividend$0.09
Next Ex-DividendN/AN/A
Last Split2:1
Next SplitN/AN/A
Last Ticker ChangeN/AN/A
Next Ticker ChangeN/AN/A

🔒 Log In To Unlock Full Data

Estimates

TEVA Estimates
MetricDateValue
EPS-$1.46
EPS Estimate$2.64
EPS Est. Change+281.10%
Revenue$16.59B
Revenue Estimate$16.94B
Revenue Est. Change+2.12%
Current Price$32.11
Price Target-$35.00
Price Tgt. Change-+9.00%

🔒 Log In To Unlock Full Data

EPS

TEVA EPS reported versus estimate values
YearEstimateReportedSurprise / Exp.
$2.31-$0.50-121.62%
$2.47-$1.46-158.96%
$2.64N/A+281.10%
$2.77N/A+290.55%
TEVA EPS reported versus estimate values chart

Revenue

TEVA revenue reported versus estimate values chart
YearEstimateReportedSurprise / Exp.
$15.37B$15.85B+3.08%
$16.42B$16.59B+1.01%
$16.94BN/A+2.12%
$16.93BN/A+2.04%
TEVA revenue reported versus estimate values chart

🔒 Log In To Unlock Full Data

Performance

TEVA Performance
MetricDateValue
Price, 1Y+52.40%
Price, 3Y+205.23%
Market Cap, 1Y+54.20%
Market Cap, 3Y+215.22%
Revenue, 1Y+4.67%
Revenue, 3Y+4.68%
EPS, 1Y-191.49%
EPS, 3Y-486.51%

🔒 Log In To Unlock Full Data

Technical Indicators

TEVA Technical Indicators
MetricDateValue
Current Price$32.11
SMA 200$19.52
SMA 200 vs Price-39.19%
SMA 50$26.70
SMA 50 vs Price-16.84%
Beta0.95
ATR$0.74
14-Day RSI76.76
10-Day Volatility24.64%
1-Year Volatility45.57%

Dividends

TEVA Dividends
MetricDateValue
Last Paid$0.09
UpcomingN/AN/A
Dividend Yield-
Total Dividend-
Dividends Paid$0.00
Payout Ratio0.00%

🔒 Log In To Unlock Full Data

Income & Profitability

TEVA Income & Profitability
MetricDateValue
Revenue$16.59B
EPS-$1.46
Gross Profit$8.06B
Gross Margin48.74%
Operating Profit$3.36B
Operating Margin20.33%
Net Income-$1.97B
Net Margin-9.91%
EBITDA$690.00M

🔒 Log In To Unlock Full Data

Financial Health

TEVA Financial Health
MetricDateValue
Debt To Equity3.31
Current Ratio0.98
Quick Ratio0.75
-
F-Score7
Altman Z-Score0.50

Valuations

TEVA Valuations
MetricDateValue
PE Ratio52.36
PS Ratio2.18
PB Ratio5.08
EV/EBITDA11.19
Enterprise ValueN/A-

Balance Sheet

TEVA Balance Sheet
MetricDateValue
Book Value$5.37B
Cash & Equivalents$3.30B
Total Assets$39.33B
Current Assets$12.55B
Total Liabilities$33.61B
Current Liabilities$12.80B
Total Debt$18.17B
Short Term Debt$1.78B
Accounts Payable$2.20B

Expenses

TEVA Expenses
MetricDateValue
Total Expenses$13.18B
Operating Expenses$4.70B
Cost Of Goods Sold$8.48B
SG&A$3.70B
D&A$1.06B
Interest Expense$0.00
Income Tax$676.00M

Cash Flow

TEVA Cash Flow
MetricDateValue
CFO$2.55B
CFI-$565.67M
CFF-$1.74B
Capex$500.36M
Free Cash Flow$2.05B

Recent analyst updates

TEVA Recent analyst updates
MetricDateValue
Piper Sandler→
Goldman Sachs→
JP Morgan→
Barclays
B of A Securities→
Goldman Sachs→
Scotiabank
JP Morgan→
JP Morgan→
UBS→

Analyst sentiment

Sentiment over the past month
TEVA analyst sentiment distribution chart

Institutional ownership

Largest institutional holders by ownership percentage
TEVA institutional ownership distribution chart

Screeners with TEVA

Data Sources & References

  1. TEVA Official Website www.tevapharm.com
  2. Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/818686/000119312525266895/0001193125-25-266895-index.htm
  3. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/818686/000119312525020826/0001193125-25-020826-index.htm
  4. TEVA Profile on Yahoo Finance finance.yahoo.com/quote/TEVA
  5. TEVA Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/teva

FAQ

  • What is the ticker symbol for Teva Pharmaceutical Industries Limited?

    The ticker symbol for Teva Pharmaceutical Industries Limited is NYSE:TEVA

  • Does Teva Pharmaceutical Industries Limited pay dividends?

    No, Teva Pharmaceutical Industries Limited does not pay dividends

  • What sector is Teva Pharmaceutical Industries Limited in?

    Teva Pharmaceutical Industries Limited is in the Healthcare sector

  • What industry is Teva Pharmaceutical Industries Limited in?

    Teva Pharmaceutical Industries Limited is in the Specialty & Generic Drug Manufacturers industry

  • What country is Teva Pharmaceutical Industries Limited based in?

    Teva Pharmaceutical Industries Limited is headquartered in Israel

  • When did Teva Pharmaceutical Industries Limited go public?

    Teva Pharmaceutical Industries Limited initial public offering (IPO) was on February 16, 1982

  • Is Teva Pharmaceutical Industries Limited in the S&P 500?

    No, Teva Pharmaceutical Industries Limited is not included in the S&P 500 index

  • Is Teva Pharmaceutical Industries Limited in the NASDAQ 100?

    No, Teva Pharmaceutical Industries Limited is not included in the NASDAQ 100 index

  • Is Teva Pharmaceutical Industries Limited in the Dow Jones?

    No, Teva Pharmaceutical Industries Limited is not included in the Dow Jones index

  • When was Teva Pharmaceutical Industries Limited last earnings report?

    Teva Pharmaceutical Industries Limited's most recent earnings report was on November 5, 2025

  • When does Teva Pharmaceutical Industries Limited report earnings?

    The next expected earnings date for Teva Pharmaceutical Industries Limited is January 28, 2026